FDA Rules for Dietary Supplements: What Consumers Should Know
FDA rules for dietary supplements differ sharply from the rules for prescription and over-the-counter drugs. Most supplements do not receive FDA premarket approval for safety, effectiveness or labeling, but manufacturers still have legal duties covering safety, manufacturing, labels, claims and serious adverse-event reporting.
Dietary supplements are regulated products, but regulation is not the same as premarket approval.
FDA rules for dietary supplements start with DSHEA
DSHEA created the modern statutory framework for dietary supplements in 1994. A dietary supplement is intended to supplement the diet, is taken by mouth and contains one or more dietary ingredients such as vitamins, minerals, herbs, amino acids or other qualifying substances. The product must be labeled as a dietary supplement or with a similar descriptive identity.
The legal category depends on intended use as well as ingredients and labeling. A capsule called a supplement can become subject to drug requirements if its claims show that it is intended to diagnose, cure, mitigate, treat or prevent disease.
FDA rules for dietary supplements: premarket and postmarket roles
Company responsibilities
Use lawful ingredients, evaluate safety, follow manufacturing rules, create accurate labels, substantiate claims and submit required notifications and reports.
FDA responsibilities
Inspect facilities, review labels and websites, monitor reports, sample products, publish safety communications and act against violative products.
This division explains why a product may be sold without an FDA approval letter yet still violate federal law. It also explains why the absence of an FDA warning does not prove that a product has been individually reviewed.
FDA rules for new dietary ingredients
A new dietary ingredient, or NDI, is generally a dietary ingredient that was not marketed in the United States before October 15, 1994. When the notification requirement applies, the manufacturer or distributor must send FDA a new dietary ingredient notification at least 75 days before introducing the supplement into interstate commerce.
The submission must provide the basis for concluding that a supplement containing the NDI will reasonably be expected to be safe. An NDIN is a safety notification, not product approval. FDA can acknowledge the submission, identify deficiencies or raise safety concerns without converting the ingredient into an “FDA-approved supplement.”
Some NDI situations are exempt, including certain ingredients present in the food supply as food in a form not chemically altered. The analysis can be technical, so manufacturers should use current FDA guidance and qualified regulatory counsel.
FDA rules for dietary supplements: five label requirements
FDA’s dietary supplement labeling guide identifies five core statements:
- A statement of identity, such as “dietary supplement” or an appropriate type such as “herbal supplement.”
- The net quantity of contents.
- Nutrition information in a Supplement Facts panel.
- An ingredient list, including appropriate “other ingredients.”
- The name and place of business of the manufacturer, packer or distributor.
The Supplement Facts panel generally lists serving size, servings per container, dietary ingredients and amounts per serving. A percent Daily Value appears when FDA has established one. Required information must meet placement, prominence and formatting rules—not merely appear somewhere in small print.
FDA rules for dietary supplement claims
| Claim category | What it communicates | Key regulatory point |
|---|---|---|
| Nutrient content claim | Characterizes the level of a nutrient, such as “high” or “low” | Must use authorized terms and meet applicable conditions |
| Health claim | Links a substance with reduced risk of a disease or health-related condition | Requires authorization or another recognized FDA pathway and qualifying language when applicable |
| Structure/function claim | Describes an effect on normal body structure or function, such as supporting normal bone health | Does not receive ordinary preapproval, but must be truthful, substantiated, notified to FDA and paired with the statutory disclaimer |
| Disease claim | Claims to diagnose, treat, cure, mitigate or prevent disease | Can cause the product to be regulated as a drug unless another lawful provision applies |
A company using a structure/function, general well-being or certain classical nutrient-deficiency claim in labeling must notify FDA within 30 days after first marketing the product with the claim. The required disclaimer states that FDA has not evaluated the statement and that the product is not intended to diagnose, treat, cure or prevent disease.
The disclaimer is not permission to make an unsupported claim. The firm must possess substantiation that the statement is truthful and not misleading. FDA reviews labels and other labeling, including linked websites, to determine the product’s intended use.
Manufacturing requirements under 21 CFR Part 111
Current good manufacturing practices, or cGMPs, apply to manufacturing, packaging, labeling and holding operations for dietary supplements. They require a production and process-control system designed to ensure quality, including specifications for identity, purity, strength, composition and contaminant limits where appropriate.
Requirements address qualified personnel, sanitation, equipment, component controls, master manufacturing records, batch records, laboratory operations, packaging, labels, returned products, complaints and records. FDA can inspect facilities and review whether the company follows its written procedures.
A “GMP” badge is not FDA approval. Companies are legally expected to comply with applicable cGMP rules. Independent certification may add product-quality information, but consumers should verify its scope using our third-party supplement testing guide.
Serious adverse-event reporting rules
Manufacturers, packers and distributors whose name appears on a dietary supplement label must submit serious adverse-event reports they receive to FDA within 15 business days. They must also maintain applicable records. A serious event may involve death, a life-threatening experience, hospitalization, persistent disability, a birth defect or medical intervention needed to prevent such an outcome.
Consumers and healthcare professionals can report problems directly to FDA. If a supplement may have caused a serious reaction, FDA advises stopping the product, seeking medical care or advice and submitting a safety report. Keep the container, lot number, receipt and a complete list of other supplements and medicines.
FDA enforcement after a product reaches the market
FDA uses inspections, product sampling, adverse-event reports, complaints, scientific literature, import screening and label review to identify violations. Depending on the facts and legal authority, actions can include warning letters, import alerts, public safety notices, recalls, product seizures, injunctions and criminal enforcement.
Common concerns include undeclared drug ingredients, unsafe ingredients, missing NDI notifications, disease claims, inaccurate labels and manufacturing failures. Products marketed for weight loss, sexual enhancement, bodybuilding or rapid pain relief have repeatedly attracted scrutiny because some have contained hidden pharmaceutical ingredients.
A recall does not necessarily mean FDA approved the product earlier. It is a corrective action after a problem is identified. Likewise, a warning letter states the agency’s position about observed violations and requests correction; it is not a certification program for competing products.
FDA labeling and FTC advertising work together
FDA primarily regulates supplement products, labels and labeling, while the Federal Trade Commission focuses on advertising. The FTC requires advertising to be truthful, not misleading and supported before dissemination. Objective health and safety claims generally require competent and reliable scientific evidence.
Website pages, social posts, testimonials, influencer content, before-and-after images and implied messages can all communicate claims. A compliant Supplement Facts panel cannot cure deceptive advertising, and an asterisk cannot contradict the main message consumers reasonably take from an ad.
A consumer checklist for FDA-related claims
- Reject “FDA approved supplement” language. Ordinary dietary supplements are not FDA-approved for safety or effectiveness before sale.
- Identify the product category. Confirm that the front calls it a dietary supplement and read the intended-use claims.
- Read all five label components. Compare the identity, quantity, Supplement Facts, ingredients and responsible company.
- Separate structure/function from disease claims. “Supports normal function” is different from promising to treat a disease.
- Look beyond the disclaimer. The DSHEA disclaimer does not show that FDA reviewed or agreed with the claim.
- Check FDA safety pages. Search current warning letters, recalls and safety communications for the product and company.
- Review interactions. Regulation does not make a supplement appropriate with your medicines or conditions.
- Report serious problems. Preserve the lot information and submit an adverse-event report to FDA.
Frequently asked questions
Does FDA approve dietary supplements before they are sold?
Generally, no. FDA does not approve dietary supplements for safety and effectiveness or approve their labels before sale. Companies are responsible for compliance, while FDA conducts oversight and enforcement.
What is the 75-day new dietary ingredient rule?
When an NDI notification is required, the manufacturer or distributor must submit safety-basis information to FDA at least 75 days before introducing the NDI-containing supplement into interstate commerce.
What does the FDA disclaimer on a supplement mean?
It states that FDA has not evaluated the structure/function statement and that the product is not intended to diagnose, treat, cure or prevent disease. It does not mean FDA endorses the claim.
Can supplements claim to treat a disease?
A disease-treatment or prevention claim can make the product subject to drug requirements. Lawful supplement claims must stay within applicable claim categories and be truthful and substantiated.
How quickly must companies report serious adverse events?
A responsible firm must submit a serious adverse-event report it receives to FDA within 15 business days. Consumers and healthcare professionals can also report directly to FDA.
Sources
- U.S. Food and Drug Administration: FDA 101 — Dietary Supplements
- FDA: How to Submit New Dietary Ingredient Notifications
- FDA: Structure/Function and Related Claim Notifications
- FDA: Label Claims for Foods and Dietary Supplements
- FDA: General Dietary Supplement Labeling
- FDA: Dietary Supplement Nutrition Labeling
- FDA: Dietary Supplement cGMP Final Rule Backgrounder
- FDA: How to Report a Problem with Dietary Supplements
- FDA: Dietary Supplement Adverse-Event Reporting
- Federal Trade Commission: Health Products Compliance Guidance
Legal and editorial note: This article is general consumer education, not legal advice. Federal statutes, regulations, guidance and enforcement priorities can change, and specific products may also be subject to state or other federal requirements.
